Primitive AML progenitors from most CD34+ patients lack CD33 expression but progenitors from many CD34- AML patients express CD33

Cytotherapy

Volumn 9, Issue 2, 2007, Pages 194-204

  Vercauteren, S M ^a,b   Zapf, R ^a,b   Sutherland, H J ^a,b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD34 SELECTION; CELL CULTURE; CELL HETEROGENEITY; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOGENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; STEM CELL; TARGET CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL PROLIFERATION; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MICE; MICE, INBRED NOD; MICE, SCID; STEM CELL TRANSPLANTATION; TUMOR STEM CELLS;

EID: 34047109219     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240601164042     Document Type: Article

References (34)

1. Sutherland, HJ, Blair, A. and Zapf, RW. (1996) Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood, 87, pp. 4754-4761.
2. -. Blood, 92, pp. 4325-4335.
3. Bonnet, D. and Dick, JE. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3, pp. 730-736.
4. Terstappen, LWMM, Huang, S. and Safford, M. (1991) Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood, 77, pp. 1218-1227.
5. Sutherland, HJ, Eaves, CJ and Eaves, AC (1989) Differential expression of antigens on cells that initiate haemopoiesis in long-term human marrow culture. Oxford University Press, pp. 910-912. Oxford University Press
6. Sutherland, HJ, Eaves, CJ and Eaves, AC (1989) Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood, 74, pp. 1563-1570.
7. Blair, A., Hogge, DE and Ailles, LE (1997) Lack of expression of Thy-1 (CD90) on acute myeloid leukaemia cells with long-term proliferative ability in vitro and in vivo. Blood, 89, pp. 3104-3112.
8. Reuss-Borst, MA, Buhring, HJ and Schmidt, H. (1994) AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia, 8, pp. 258-263.
9. Noto, R Di, Pardo, C Lo and Schiavone, EM (1996) Stem cell factor receptor (c-kit, CD117) is expressed on blast cells from most immature types of acute myeloid malignancies but is also a characteristic of a subset of acute promyelocytic leukemia. Br J Haematol, 92, pp. 562-564.
10. Osawa, M., Hanada, KI and Hamada, H. (1996) Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science, 273, pp. 242-245.
11. Bhatia, M., Bonnet, D. and Murdoch, B. (1998) A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med, 4, pp. 1038-1045.
12. Terpstra, W., Prins, A. and Ploemacher, RE (1996) Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukaemia. Blood, 87, pp. 2187-2194.
13. Vercauteren, SM and Sutherland, HJ. (2001) CD133 (AC133) expression on AML cells and progenitors. Cytotherapy, 3, pp. 449-459.
14. Brenner, MK, Rill, DR and Moen, RC (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, 341, pp. 85-86.
15. Tanimoto, M., Scheinberg, DA and Cordon-Cardo, C. (1989) Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195. Leukemia, 3, pp. 339-348.
16. Andrews, RG, Takahashi, M. and Segal, GM (1986) The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors. Blood, 68, pp. 1030-1035.
17. Andrews, RG, Singer, JW and Bernstein, ID. (1989) Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med, 169, pp. 1721-1731.
18. Dinndorf, PA, Andrews, RG and Bnejamin, D. (1986) Expression of normal myeloid-associated antigens by acute leukemia cells. Blood, 67, pp. 1048-1053.
19. Baer, MR, Stewart, CC and Dodge, RK (2001) High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implication for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood, 97, pp. 3574-3580.
20. Legrand, O., Perrot, JY and Baudard, M. (2000) The immunophenotype of 177 adults with acute myeloid leukemia: Proposal of a prognostic score. Blood, 96, pp. 870-877.
21. Brown, P de Nully, Jurlander, J. and Pedersen-Bjergaard, J. (1997) The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia. Leuk Res, 21, pp. 985-995.
22. Sievers, EL, Larson, RA and Stadtmauer, EA (2001) Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse. J Clin Oncol, 19, pp. 3244-3254.
23. Larson, RA, Boogaerts, M. and Estey, E. (2002) Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia, 16, pp. 1627-1636.
24. Verlinden, SF, van Es, HH and van Bekkum, DW. (1998) Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice. Exp Hematol, 26, pp. 627-630.
25. Fraser, C., Eaves, CJ and Kalousek, DK. (1987) Fluorodeoxyuridine synchronization of hemopoietic colonies. Cancer Genet Cytogenet, 24, pp. 1-6.
26. Lau, YF, Huang, JC and Dozy, AM (1984) A rapid screening test for antenatal sex determination. Lancet, pp. 14-16.
27. Lapidot, T., Sirard, C. and Vormoor, J. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367, pp. 645-648.
28. Wouters, R. and Lowenberg, B. (1984) On the maturation order of AML cells: A distinction on the basis of self-renewal properties and immunologic phenotypes. Blood, 63, pp. 684-689.
29. Sabbath, KD, Ball, ED and Larcom, P. (1985) Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J Clin Invest, 75, pp. 746-753.
30. Kabral, A., Bradstock, KF and Grimsley, P. (1988) Immunophenotype of clonogenic cells in myeloid leukaemia. Leuk Res, 12, pp. 51-59.
31. Guan, Y., Ralph, S. and Hogge, DE. (2002) Polyclonal normal hematopoietic progenitors in patients with acute myeloid leukemia. Exp Hematol, 30, pp. 721-728.
32. Matsui, H., Takeshita, A. and Naito, K. (2002) Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers. Leukemia, 16, pp. 813-819.
33. Ailles, LE, Gerhard, B. and Kawagoe, H. (1999) Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood, 94, pp. 1761-1772.
34. Lo-Coco, F., Cimino, G. and Breccia, M. (2004) Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia. Blood, 104, pp. 1994-1999.